Addressing these issues requires coordinated standards, longer follow-up studies, and scalable vascularization solutions
However, insufficient evidence exists to justify the discontinuation of GLP-1 RAs before the procedure, and the ideal cessation timing for these agents remains indeterminate
Zhang Y, Sun B, Feng D, Hu H, Chu M, Qu Q, et al
RefsumHSmithADUelandPMNexoEClarkeRMcPartlinJet al
Any there any side effects of GLP-1 medications
If your primary concern is insulin resistance, blood sugar regulation, or cortisol-driven weight gain, the metabolic benefits of microdosing often appear before significant weight loss